home / stock / dxcm / dxcm quote
Last: | $110.91 |
---|---|
Change Percent: | 0.08% |
Open: | $112.4 |
Close: | $110.91 |
High: | $112.49 |
Low: | $109.81 |
Volume: | 1,350,991 |
Last Trade Date Time: | 07/03/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$110.91 | $112.4 | $110.91 | $112.49 | $109.81 | 1,350,991 | 07-03-2024 |
$112.49 | $112.17 | $112.49 | $113.08 | $111 | 1,778,550 | 07-02-2024 |
$112.17 | $113 | $112.17 | $115.295 | $111 | 2,583,626 | 07-01-2024 |
$113.38 | $114.29 | $113.38 | $114.58 | $111.86 | 5,429,492 | 06-28-2024 |
$114.54 | $112.69 | $114.54 | $114.97 | $112.49 | 2,473,875 | 06-27-2024 |
$113.51 | $110.28 | $113.51 | $113.83 | $110.16 | 2,543,965 | 06-26-2024 |
$110.31 | $111.36 | $110.31 | $111.82 | $108.71 | 4,093,632 | 06-25-2024 |
$110.57 | $116.41 | $110.57 | $116.6 | $109.7505 | 4,690,341 | 06-24-2024 |
$116.64 | $117.18 | $116.64 | $117.27 | $114.22 | 7,133,365 | 06-21-2024 |
$116.07 | $116.94 | $116.07 | $117.12 | $115.49 | 1,875,319 | 06-20-2024 |
$116.64 | $116.53 | $116.64 | $117.49 | $116.13 | 2,192,895 | 06-19-2024 |
$116.64 | $116.53 | $116.64 | $117.49 | $116.13 | 2,192,895 | 06-18-2024 |
$116.53 | $115.18 | $116.53 | $117.91 | $114.65 | 3,379,666 | 06-17-2024 |
$115.95 | $113.55 | $115.95 | $116.01 | $113.23 | 1,813,855 | 06-14-2024 |
$113.81 | $115.16 | $113.81 | $116.33 | $113.67 | 2,064,703 | 06-13-2024 |
$117.2 | $116.6 | $117.2 | $118.8 | $115.96 | 2,385,508 | 06-12-2024 |
$116.9 | $116.92 | $116.9 | $118.12 | $115.72 | 2,223,270 | 06-11-2024 |
$116.57 | $115.05 | $116.57 | $116.9599 | $114.62 | 2,298,436 | 06-10-2024 |
$115.79 | $114.73 | $115.79 | $116.58 | $114.2416 | 3,009,534 | 06-07-2024 |
$115.3 | $117.5 | $115.3 | $118.175 | $114.2 | 3,509,857 | 06-06-2024 |
News, Short Squeeze, Breakout and More Instantly...
DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its second quarter 2024 financial results after market close on Thursday, July 25, 2024. Management will hold a conference call to review the company's second quarter 2024 performance starting at 4:30 p.m. (Eastern Time) on the...
The world’s most connected continuous glucose monitoring system ‡ , Dexcom G6, now connects with the Omnipod® 5 Automated Insulin Delivery (AID) System in The Netherlands. DexCom, Inc. (Nasdaq: DXCM), a global leader in real-time continuous glucose monitoring fo...